Showing results (1711-1720 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|September 13, 2011
Critical assessment of belgian reimbursement dossiers of orphan drugsAlain Denis, Lut Mergaert, Christel Fostier, et al.Pharmacoeconomics|February 10, 2012
Changes in antipsychotic medication use after implementation of a Medicaid mental health carve-out in the USJohn RobstPharmacoeconomics|October 13, 2011
Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countriesGreg L PloskerPharmacoeconomics|December 22, 2011
Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisalMichael Holmes, Christopher Carroll, Diana PapaioannouPharmacoeconomics|April 9, 2011
The direct medical costs associated with suspected heparin-induced thrombocytopeniaNatasha Nanwa, Nicole Mittmann, Sandra Knowles, et al.Pharmacoeconomics|August 16, 2011
Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal diseaseGreg L PloskerPharmacoeconomics|August 18, 2011
Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literatureGery P Guy, Donatus U EkwuemePharmacoeconomics|April 21, 2011
Modelling the epidemiology of infectious diseases for decision analysis: a primerMark Jit, Marc BrissonPharmacoeconomics|April 21, 2011
Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countriesGreg L PloskerPharmacoeconomics|June 16, 2011
Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countriesOmar Galárraga, Veronika J Wirtz, Alejandro Figueroa-Lara, et al.Pageof 336